Comparative Ethnopharmacological Insights Into Anti-Inflammatory Phytochemicals From Indian and Chinese Medicinal Plants in the Management of Rheumatoid Arthritis
Sep 2026· Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders· 0 citations· 61 references
TL;DR
Medicinal plants from Indian and Chinese systems offer potential as supportive agents in RA management and additional research should concentrate on the aspects of standardization, mechanistic studies and clinical validation to confirm their therapeutic benefits and their safe use alongside other traditional therapies.
Abstract
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by synovial inflammation, pain and progressive joint damage. The traditional medicines of India and China have used herbal remedies for the treatment of inflammatory diseases for centuries. The ethnopharmacological history of such medicines is an asset that can be explored for the use of herbal remedies in RA.
The present study reviews medicinal plants of Indian and Chinese origin, emphasizing phytochemicals with demonstrated anti-inflammatory, anti-oxidant and immunomodulatory activities relevant to rheumatoid arthritis.
A narrative literature review was performed using PubMed, Scopus, Web of Science and Google Scholar databases up to 2025. Literature that described the isolation, characterization, and biological evaluation of active compounds from traditional medicinal plants was taken into account.
Phytoconstituents such as flavonoids, terpenoids, saponins, alkaloids and polyphenols exhibit inhibition of pro-inflammatory mediators including TNF-α, IL-1β, IL-6, COX-2 and NF-κB. Several plants like
Curcuma longa, Boswellia serrata, Zingiber officinale
and
Camellia sinensis
demonstrate potential anti-inflammatory and anti-oxidant properties, which make them beneficial in treating arthritis.
Medicinal plants from Indian and Chinese systems offer potential as supportive agents in RA management. Additional research should concentrate on the aspects of standardization, mechanistic studies and clinical validation to confirm their therapeutic benefits and their safe use alongside other traditional therapies.
The findings underscore the promise of Fabaceae plants as valuable natural sources for developing safe and effective anti-arthritic agents, war-ranting further pharmacological and clinical investigations to establish their efficacy and safety profiles.
Sukanya Vijayan, Thirumal Margesan· Current Drug Therapy· 0 citations
Traditional Chinese medicine (TCM) represents a valuable resource for RA drug discovery and integrative treatment strategies, and further in-depth investigation is needed into its specific molecular targets, optimal formulations, and long-term clinical outcomes to facilitate its global translation and application.
Jian-Ting Wen, Jian Liu, L. Wan et al.· Phytotherapy Research· 0 citations
This work supports the development of plant-based substitutes for existing medications by integrating contemporary molecular insights with traditional ethnopharmacological expertise, highlighting the therapeutic potential of phytochemicals for treating pain and inflammation-associated illnesses.
Ashutosh Mohanty, G. Pattnaik, J. Dash· Mini-Reviews in Medical Chem...· 0 citations
It is suggested that GLFME possesses significant antioxidant and anti-inflammatory pharmacological potential and may serve as a promising natural source for future nutraceutical and therapeutic development.
Mst Soheli Akhter Nifa, M. Abdullah, Monirul Islam et al.· Journal of Ethnopharmacology· 2 citations
Ethnopharmacological relevance Australian Indigenous medicinal plants represent a valuable yet underexplored source of bioactive compounds with potential therapeutic relevance. The Iningai community of Central Queensland has traditionally used native plants to manage conditions associated with inflammation, pain, infec...
Felix Wambua Muema, Suzanne Thompson, Gerry Turpin et al.· bioRxiv· 0 citations
The multi-barrier mechanism of APs, combined with a favorable safety profile, positions APs as a promising adjunctive therapy for IBD, however, the current evidence is predominantly derived from animal models.
Jie Gong, Guiping Guan, Shuangshuang Wang et al.· Journal of Ethnopharmacology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.